Apple Watch redesigned without blood oxygen monitoring to avoid import ban

Enlarge / The Apple Watch Series 9. (credit: Apple)

Apple has developed a backup plan for if the Apple Watch Series 9 and Ultra 2 are import banned again. As it currently appeals the US International Trade Commission’s (ITC’s) ruling that its watches violate a patent owned by Masimo, Apple has come up with a software workaround that strips its current smartwatches of their controversial blood oxygen monitoring capabilities.

In January 2023, the ITC ruled that the Watch violated one of California-headquartered Masimo’s light-based pulse oximetry patents. The Apple Watch Series 6, which came out in 2020, was the first Apple smartwatch to use a pulse oximeter sensor.

Facing a US import ban of the current Watch Series 9 and Watch Ultra 2, both released in September 2023, Apple started pulling the smartwatches on December 21. But on December 27, Apple, which filed its appeal against the ITC’s ruling on December 26 (after US President Joe Biden declined to overrule the ITC ruling), received an emergency interim stay from the US Court of Appeals for the Federal Circuit, allowing it to continue selling the Watch.